TP53 and central nervous system cancer: Thus, older studies commonly analysed combined cohorts of either ‘LGG’ or ‘gliomas’ (that also included the much more aggressive glioblastoma) [20,26,73,74,85] and concluded that there was no prognostic effect of TP53 in LGG or TP53 mutant cases corresponding to a decreased OS.